The key is that we need more prospective, randomized, controlled trials—such as the multicenter START—that address active surveillance. Again, I congratulate the researchers on excellent work, and look forward to further studies of active surveillance and new information about this hot topic.
Judd W. Moul, M.D., is professor and chief of the Division of Urologic Surgery, and director of the Duke Prostate Center at Duke University, Durham, N.C. He had no relevant conflicts of interest.
Vitals